Fetal exposure to mycophenolic acid products may increase risk of birth defects News-Medical.net Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions. Results of this study will be presented at ... Kidney Transplant Rejection Drugs Tied to Pregnancy Risks in Study Stopping transplant drugs before conception benefits fetus |
